Local Institution

Rimini 47923

0 studies enrolling now · 9 studies all time

What they study most

Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma, Albuminuria, Lymphoma, Melanoma, Multiple Myeloma, Non Small Cell Lung Cancer, Non-small Cell Lung Cancer (NSCLC), Prostate Cancer, Unresectable Stage III or IV Malignant Melanoma

Studies at this site

• Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025) — Completed
• Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• Phase I Combination Ixabepilone + Cisplatin — Completed
• Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• Study of Immunotherapy to Treat Advanced Prostate Cancer — Completed
• Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010) — Completed
• A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies — Completed
• Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer — Stopped early
• Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria — Completed